BioCentury
ARTICLE | Politics, Policy & Law

Scientists warn Trump immigration ‘pause’ will harm biopharma innovation

June 23, 2020 4:41 PM UTC
Updated on Jun 23, 2020 at 10:32 PM UTC

President Donald Trump’s decision to bar most employment-based visas through year-end could have a broad impact on the U.S. biopharma industry, which is heavily dependent on temporary and permanent immigrants to fill jobs from junior scientists to CEOs.

In addition to the proclamation, a broad exemption in an April 22 ban for individuals involved in medical fields, including research, has been narrowed to apply only to individuals working directly on COVID-19. ...